Atlas Trials

Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients

Clinical trial NCT00002012 · COMPLETED

Trial details

NCT number
NCT00002012
Sponsor
Interferon Sciences
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
HIV Infections
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.